Kalaris Therapeutics (KLRS) Prepaid Assets (2019 - 2026)
Kalaris Therapeutics (KLRS) posted quarterly Prepaid Assets of $861000.0 for Q1 2026, down 29.25% year-over-year from $1.2 million in Q1 2025, and up 308.06% quarter-over-quarter from $211000.0 in Q4 2025.
Kalaris Therapeutics (KLRS) Prepaid Assets (2019 - 2026) Analysis & Trends
Kalaris Therapeutics' Prepaid Assets history runs 8 years deep, the most recent figure standing at $861000.0 for Q1 2026.
- In Q1 2026, Prepaid Assets fell 29.25% year-over-year to $861000.0; the TTM figure through Mar 2026 stood at $861000.0 (down 29.25% YoY), while the FY2025 annual figure was $211000.0, down 78.18% from the prior year.
- Prepaid Assets for Q1 2026 stood at $861000.0, up from $211000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $7.5 million in Q1 2023, with the low at $199000.0 in Q3 2025.
- The 5-year median for Prepaid Assets is $1.2 million (2025), against an average of $2.8 million.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets soared 122.15% in 2022, then slumped 95.14% in 2024.
- Kalaris Therapeutics' Prepaid Assets stood at $7.1 million in 2022, then sank by 50.9% to $3.5 million in 2023, then slumped by 72.26% to $967000.0 in 2024, then plunged by 78.18% to $211000.0 in 2025, then jumped by 308.06% to $861000.0 in 2026.
- Business Quant data shows KLRS's Prepaid Assets at $861000.0 in Q1 2026, $211000.0 in Q4 2025, and $199000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Kalaris Therapeutics | 100.19 Mn | 100.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.87 Mn |
| Mar 31, 2026 | 861,000.00 |
| Dec 31, 2025 | 211,000.00 |
| Sep 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 249,000.00 |
| Mar 31, 2025 | 1.22 Mn |
| Dec 31, 2024 | 967,000.00 |
| Sep 30, 2024 | 626,000.00 |
| Jun 30, 2024 | 230,000.00 |
| Mar 31, 2024 | 771,000.00 |
| Dec 31, 2023 | 3.49 Mn |
| Sep 30, 2023 | 5.89 Mn |
| Jun 30, 2023 | 4.74 Mn |
| Mar 31, 2023 | 7.46 Mn |
| Dec 31, 2022 | 7.10 Mn |
| Sep 30, 2022 | 5.57 Mn |
| Jun 30, 2022 | 3.75 Mn |
| Mar 31, 2022 | 4.89 Mn |
| Dec 31, 2021 | 5.18 Mn |
| Sep 30, 2021 | 5.88 Mn |